Greater Glasgow and Clyde Medicines

CMOP Publications                                                                                                                                                                                                                                                          

Please find below a list of our publications:

 

Dunlop E, Ferguson A, Mueller T, et al (2022). What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer. Support Care Cancer 2022;30:3141-3150. https://doi.org/10.1007/s00520-021-06724-6 

 

Rana D, Geue C, Baillie K. et al. (2022) Healthcare Costs for Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide. PharmacoEconomics Open 2022;6:303-313. https://doi.org/10.1007/s41669-021-00307-1

 

Mueller, T, Laskey J, Baillie K, et al. (2022) Opportunities and challenges when using record linkage of routinely collected electronic health care data to evaluate outcomes of systemic anti-cancer treatment in clinical practice. Health Informatics Journal 2022;18:1-17. https://doi.org/10.1177%2F14604582221077055 

 

Baillie K, Reed N, Laskey J, et al. (2021) Neoadjuvant chemotherapy in locally advanced cervical cancer: real-world data from the Cancer Medicines Outcomes Programme (CMOP). European Journal of Gynaecological Oncology 2021;42(5):926-935. https://doi.org/10.31083/j.ejgo4205140

 

Baillie K, Reed N, Pan J, et al. (2021) Retrospective cohort study of neoadjuvant chemotherapy followed by tailored surgery in locally advanced sphincter-threatening vulval cancer: an alternative to exenteration?. European Journal of Gynaecological Oncology. 2021;42(5):917-925. https://doi.org/10.31083/j.ejgo4205139 

 

Mueller T, Laskey J, Baillie K, et al. (2021) Opportunities and challenges when using record linkage of routinely collected electronic health care data to evaluate outcomes of systemic anti-cancer treatment in clinical practice. medRxiv 2021. doi.org/10.1101/2021.05.28.21257611 [Pre-Print]

 

Baillie K, Mueller T, Pan J, et al. (2020) Use of record linkage to evaluate treatment outcomes and trial eligibility in a real-world metastatic prostate cancer population in Scotland. Pharmacoepidemiology & Drug Safety 2000;29(6):653-663

 

CMOP Reports

 

The table below provides a list of our public summary reports:

 

 Reports

 Additional Information

CMOP End of Phase 1 Public Summary Report (2021) 

Report describing the work of CMOP during Phase 1 of the programme

Scottish Cancer Patient Reported Outcome Measures Forum - Meeting 1 Summary (March 2022)  

Key learning & recommendations from Meeting 1 of the Scottish Cancer Patient Reported Outcome Measures Forum

Scottish Cancer Patient Reported Outcome Measures Forum - Meeting 2 Summary (November 2022)

Key learning & recommendations from Meeting 2 of the Scottish Cancer Patient Reported Outcome Measures Forum 

CMOP Study Information Leaflet - Cervical

Leaflet providing information on the CMOP study undertaken in cervical cancer 

CMOP Study Information Leaflet - Vulval

Leaflet providing information on the CMOP study undertaken in vulval cancer